We are live on
!
Find out more
TCM
Tanaka Capital Management Portfolio holdings
AUM
$59.9M
This Fund
S&P 500
This Quarter
Est. Return
+6.72%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$45.4M
AUM Growth
+$2.62M
(+6.1%)
Cap. Flow
-$627K
Cap. Flow
% of AUM
-1.38%
Top 10 Holdings %
Top 10 Hldgs %
60.24%
Holding
58
New
4
Increased
4
Reduced
27
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NTRP
Neurotrope, Inc. Common
NTRP
|
+$1.73M |
| 2 |
AMRS
Amyris Inc.
AMRS
|
+$1.22M |
| 3 |
Inovio Pharmaceuticals
INO
|
+$644K |
| 4 |
Meta Platforms (Facebook)
META
|
+$29.4K |
| 5 |
Cameco
CCJ
|
+$24K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATTU
Attunity Ltd
ATTU
|
+$1.06M |
| 2 |
Tesla
TSLA
|
+$668K |
| 3 |
PARAA
Paramount Global Class A
PARAA
|
+$637K |
| 4 |
CPRX
Catalyst Pharmaceutical
CPRX
|
+$443K |
| 5 |
Honeywell
HON
|
+$175K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.89% |
| 2 | Healthcare | 23.89% |
| 3 | Industrials | 9.92% |
| 4 | Communication Services | 8.06% |
| 5 | Financials | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tower Semiconductor
TSEM
$27B
| $4.05M | 8.93% |
175,733
-2,830
| -2% | -$62.1K |
|
2
Ionis Pharmaceuticals
IONS
$9.39B
| $3.35M | 7.39% |
83,399
-1,554
| -2% | -$69.8K |
|
|
PARAA
3
DELISTED
Paramount Global Class A
PARAA
| $3.13M | 6.9% |
45,091
-9,525
| -17% | -$637K |
|
4
Apple
AAPL
$4.83T
| $3.07M | 6.76% |
85,432
-3,312
| -4% | -$109K |
|
5
Alaska Air
ALK
$5.07B
| $1.84M | 4.07% |
19,998
-947
| -5% | -$89.6K |
|
|
NTRP
6
DELISTED
Neurotrope, Inc. Common
NTRP
| $1.75M | 3.85% |
+91,465
| New | +$1.73M |
|
|
CELG
7
DELISTED
Celgene Corp
CELG
| $1.74M | 3.84% |
13,982
-235
| -2% | -$28.1K |
|
|
RTEC
8
DELISTED
Rudolph Technologies Inc
RTEC
| $1.59M | 3.5% |
70,827
-3,612
| -5% | -$80.6K |
|
|
9
Tesla
TSLA
$1.24T
| $1.31M | 2.89% |
70,665
-39,465
| -36% | -$668K |
|
10
Aflac
AFL
$63.9B
| $1.2M | 2.64% |
33,046
-826
| -2% | -$29.3K |
|
|
AMRS
11
DELISTED
Amyris Inc.
AMRS
| $1.14M | 2.52% |
+143,784
| New | +$1.22M |
|
|
ADXS
12
DELISTED
Advaxis Inc
ADXS
| $1.12M | 2.48% |
9,166
-96
| -1% | -$12.5K |
|
13
Qualcomm
QCOM
$176B
| $998K | 2.2% |
17,412
-439
| -2% | -$25.5K |
|
14
JetBlue
JBLU
$1.89B
| $950K | 2.09% |
46,072
-1,709
| -4% | -$34.8K |
|
15
Corcept Therapeutics
CORT
$10.3B
| $939K | 2.07% |
85,705
-1,610
| -2% | -$14.1K |
|
16
GE Aerospace
GE
$372B
| $909K | 2% |
6,368
-234
| -4% | -$33.9K |
|
17
Onto Innovation
ONTO
$13.7B
| $863K | 1.9% |
28,319
-252
| -0.9% | -$6.82K |
|
|
18
Honeywell
HON
$77.7B
| $782K | 1.72% |
6,936
-1,582
| -19% | -$175K |
|
19
Helen of Troy
HELE
$638M
| $717K | 1.58% |
7,608
-301
| -4% | -$28.4K |
|
|
SF
20
Stifel
SF
$12.1B
| $684K | 1.51% |
30,656
-304
| -1% | -$7K |
|
|
21
Inovio Pharmaceuticals
INO
$83.1M
| $642K | 1.42% |
+8,077
| New | +$644K |
|
22
Philip Morris
PM
$303B
| $626K | 1.38% |
5,548
-60
| -1% | -$6.19K |
|
23
Amgen
AMGN
$204B
| $551K | 1.21% |
3,358
-381
| -10% | -$63.3K |
|
|
CPRX
24
DELISTED
Catalyst Pharmaceutical
CPRX
| $416K | 0.92% |
241,753
-348,130
| -59% | -$443K |
|
25
MacroGenics
MGNX
$215M
| $311K | 0.69% |
16,720
-8,530
| -34% | -$165K |
|
Similar funds
GC
GCS
NI
CMANY
GMC
JCM
PCA
ACM
Tanaka Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Tanaka Capital Management held 58 positions worth $45.4M, up 6.1% from $42.7M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Tanaka Capital Management's Q1 2017 filing shows 4 new, 4 increased, 27 reduced and 3 closed positions. Its largest new stake was Neurotrope, Inc. Common: 91,465 shares worth $1.75M. The largest sale was Attunity Ltd, an estimated $1.06M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.
- Tanaka Capital Management's largest Q1 2017 buy was Neurotrope, Inc. Common: 91,465 shares worth $1.75M.
- Tanaka Capital Management added most to Meta Platforms (Facebook) in Q1 2017, an estimated $29.4K increase.
- Tanaka Capital Management's biggest Q1 2017 reduction was Tesla, cutting an estimated $668K.
- Tanaka Capital Management fully exited Attunity Ltd in Q1 2017, selling an estimated $1.06M.
- Tanaka Capital Management's ten largest holdings make up 60% of its $45.4M portfolio in Q1 2017.
- Tanaka Capital Management opened 4 new positions and closed 3 in Q1 2017.
- Tanaka Capital Management's portfolio value rose 6.1% quarter-over-quarter to $45.4M.
Based on Tanaka Capital Management's 13F filing for Q1 2017, filed 15 May 2017.